---
category: news
title: "Merck Dives Deep into AI with $610 Million+ Absci Pact"
excerpt: "Vancouver, Wash.-based Absci Corporation inked a research pact with Merck. Under the deal, Absci will leverage its Bionic Protein non-standard amino acid technology and its artificial intelligence-powered integrated Drug Creation Platform to create enzymes to meet Merckâ€™s biomanufacturing applications."
publishedDateTime: 2022-01-07T23:38:00Z
originalUrl: "https://www.pharmalive.com/merck-dives-deep-into-ai-with-610-million-absci-pact/"
webUrl: "https://www.pharmalive.com/merck-dives-deep-into-ai-with-610-million-absci-pact/"
type: article
quality: 39
heat: 39
published: false

provider:
  name: PharmaLive
  domain: pharmalive.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://www.pharmalive.com/wp-content/uploads/2022/01/Merck-Dives-Deep-into-AI-with-610-Million-Absci-Pact-BioSPace-1-7-22.jpeg"
    width: 625
    height: 350
    isCached: true

secured: "FjIJYAdWF4a+s9V/F1BWy6Ad/qHovZQbWGj5QpgbSKtWMTfqoCZmMPxD3CnRN76dZuxoyOHd3zeAhHP4P184xrTb7BAOiEvIjLAqJzDntngW9Ee3ARkkHTyvB39XlziAX/nz11LaZAOdiV9e/tvJAJiSrvAByFwcG9BGGWI3bjOXJjyNob4EMP3WYY96sYJQSa+3Ry7vRDIFG7qrXOsmeiGz82LzN+qjvNmX6Zxg72pjZbd2L5SNOo8JwnWx2oHBCWWgvV2ZJm9dMXKHcEQIR+KarwylfTO4wVgUFGbUFKrEDEWJZMCdYmQf6oniwlNYLCPtpAu3zF8Xv9LszHOpkuk3qL8FlSoow/19kxmv5BI=;IvbZ7BBIiArcfngNZTZQvw=="
---

